Search Results - "LEWALLE, P"

Refine Results
  1. 1

    Demonstration of universal control between non-interacting qubits using the Quantum Zeno effect by Blumenthal, E., Mor, C., Diringer, A. A., Martin, L. S., Lewalle, P., Burgarth, D., Whaley, K. B., Hacohen-Gourgy, S.

    Published in npj quantum information (25-07-2022)
    “…The Zeno effect occurs in quantum systems when a very strong measurement is applied, which can alter the dynamics in non-trivial ways. Despite being…”
    Get full text
    Journal Article
  2. 2

    Towards an International Classification for Patient Safety: key concepts and terms by Runciman, William, Hibbert, Peter, Thomson, Richard, Van Der Schaaf, Tjerk, Sherman, Heather, Lewalle, Pierre

    “…Background Understanding the patient safety literature has been compromised by the inconsistent use of language. Objectives To identify key concepts of…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Sweet's syndrome induced by pegfilgrastim during a myelodysplastic syndrome AREB2: A case report by Nelis, S, Azerad, M-A, Drowart, A, Lewalle, P, Efira, A

    Published in La revue de medecine interne (01-04-2019)
    “…Sweet's syndrome is an acute neutrophilic dermatosis characterized by abrupt onset of skin lesions accompanied by fever, arthralgia, leukocytosis and diffuse…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A single dose of donor lymphocytes depleted of anti-host reactive T cells (ATIR101) following T-cell-depleted haploidentical HSCT is safe and efficaceous by Roy, D, Walker, I, Maertens, J, Lewalle, P, Olavarria, E, Beguin, Y, Selleslag, D, Wagner, E, Bönig, H, Mielke, S

    Published in CYTOTHERAPY (01-05-2019)
    “…Background & Aim IntroductionEx vivo photodepletion using dibromorhodamine (ATIR101, Kiadis Pharma) enables the administration of donor lymphocytes after…”
    Get full text
    Journal Article Conference Proceeding
  7. 7
  8. 8
  9. 9

    Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report by Meuleman, N, Vanhaelen, G, Tondreau, T, Lewalle, P, Kwan, J, Bennani, J, Martiat, P, Lagneaux, L, Bron, D

    Published in Haematologica (Roma) (01-01-2008)
    “…1 Department of Clinical and Experimental Hematology, Institut Jules Bordet, Université Libre de Bruxelles (ULB) 2 Department of Neurology ,Centre Hospitalier…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study by LEWALLE, P, TRIFFET, A, DELFORGE, A, CROMBEZ, P, SELLESLAG, D, DE MUYNCK, H, BRON, D, MARTIAT, P

    Published in Bone marrow transplantation (Basingstoke) (01-01-2003)
    “…Haploidentical transplantation has become a clinical option for patients lacking a compatible donor. However, patients are still referred at advanced stages…”
    Get full text
    Journal Article
  13. 13

    Freezing of dendritic cells, generated from cryopreserved leukaphereses, does not influence their ability to induce antigen-specific immune responses or functionally react to maturation stimuli by Lewalle, P, Rouas, R, Lehmann, F, Martiat, P

    Published in Journal of immunological methods (23-06-2000)
    “…It is of practical clinical importance to be able to reinfuse into patients dendritic cells which have been previously frozen in aliquots. However, there are…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Antisense oligodeoxyribonucleotides suppress hematologic cell growth through stepwise release of deoxyribonucleotides by VAERMAN, J. L, MOUREAU, P, DELDIME, F, LEWALLE, P, LAMMINEUR, C, MORSCHHAUSER, F, MARTIAT, P

    Published in Blood (01-07-1997)
    “…Antisense oligodeoxyribonucleotides (ODNs) are now being extensively investigated in an attempt to achieve cell growth suppression through specific targeting…”
    Get full text
    Journal Article
  16. 16

    BCR-ABL Antisense Oligodeoxyribonucleotides Suppress the Growth of Leukemic and Normal Hematopoietic Cells by a Sequence-Specific But Nonantisense Mechanism by Vaerman, J.L., Lammineur, C., Moureau, P., Lewalle, P., Deldime, F., Blumenfeld, M., Martiat, P.

    Published in Blood (15-11-1995)
    “…We have examined the effect of BCR/ABL junctional antisense phosphodiester oligodeoxyribonucleotides (ODNs) on BV173 and other chronic myeloid leukemia (CML)…”
    Get full text
    Journal Article
  17. 17

    Point mutations in an infectious bovine viral diarrhoea virus type 2 cDNA transcript that yields an attenuated and protective viral progeny by Dehan, P., Couvreur, B., Hamers, C., Lewalle, P., Thiry, E., Kerkhofs, P., Pastoret, P.-P.

    Published in Vaccine (21-07-2005)
    “…An infectious cDNA clone of the hypervirulent bovine viral diarrhoea virus (BVDV) strain 890 (isolate 256) was produced by a streamlined PCR procedure. As…”
    Get full text
    Journal Article Web Resource
  18. 18

    Differences in Experimental Virulence of Bovine Viral Diarrhoea Viral Strains Isolated from Haemorrhagic Syndromes by HAMERS, C., COUVREUR, B., DEHAN, P., LETELLIER, C., LEWALLE, P., PASTORET, P.-P., KERKHOFS, P.

    Published in The veterinary journal (1997) (01-11-2000)
    “…In the late 1980s, a new hypervirulent and epidemic form of bovine viral diarrhoea virus (BVDV) infection appeared in North America. A similar but sporadic…”
    Get full text
    Journal Article Web Resource
  19. 19

    Long-Term Follow-up of Residual Disease in Acute Lymphoblastic Leukemia Patients in Complete Remission Using Clonogeneic IgH Probes and the Polymerase Chain Reaction by Nizet, Y., Van Daele, S., Lewalle, P., Vaerman, J.L., Philippe, M., Vermylen, C., Cornu, G., Ferrant, A., Michaux, J.L., Martiat, P.

    Published in Blood (01-09-1993)
    “…We sequentially studied bone marrow (BM) samples of 25 patients in complete remission of an acute lymphoblastic leukemia (ALL) using a simplified polymerase…”
    Get full text
    Journal Article
  20. 20

    Assessment of the clinical and virological protection provided by a commercial inactivated bovine viral diarrhoea virus genotype 1 vaccine against a BVDV genotype 2 challenge by Hamers, C., Couvreur, B., Dehan, P., Letellier, C., Fischer, L., Brun, A. J., Lewalle, P., Michaux, C., Pastoret, P-P., Kerkhofs, P.

    Published in Veterinary record (23-08-2003)
    “…A new genotype of bovine viral diarrhoea virus (BvDv), designated BVDV-2, has emerged in the last decade and in recent years the prevalence of BVDV-2 strains…”
    Get full text
    Journal Article Web Resource